BOSTON, Sept. 4 /PRNewswire/ -- The Cytokine Institute (TCI), a Los Angeles-based DNA and genomics research and consulting group, announced today the opening of a new office in the heart of Boston's legal and financial district. The organization measures and analyzes the effects of chemical and toxic exposures on human health and the environment. Through its Boston-based consulting arm, Green Reach Consulting, TCI now offers a range of business, financial, litigation, and industrial consulting services focused on toxic tort issues, as well as environmental, healthcare, chemical, and hazard management.
The Cytokine Institute, founded by medical toxicologist Bruce Gillis, M.D., M.P.H, pioneered the genomics-based technology, msds1(TM), in concert with the faculty and staff of the University of Illinois College of Medicine. The technology analyzes how 36,000 parameters of an individual's DNA are affected by specific chemicals -- including benzene, chromium, asbestos and formaldehyde.
It is the first DNA evidence of its kind to be used in civil court, enabling attorneys and judges to weed out baseless and frivolous lawsuits while providing scientific evidence in support of those who have in fact suffered injury. Companies facing class-action lawsuits are now benefiting from TCI's technology and protocols.
"For the first time, we can now apply an impartial methodology for providing scientifically-based evidence in liability and workers compensation cases," said Dr. Gillis. "By eliminating our justice system's dependence on circumstantial evidence and often-unreliable expert witnesses, the technology's potential benefits for healthcare, insurance and tort litigation are profound."
The technology is currently being used in numerous workers compensation cases pending in California. Insurers, chemical companies, law firms and the American Bar Association are carefully watching its development for further use in courtrooms around the country.
Gary M. Rodrigues has joined The Cytokine Institute and Green Reach Consulting as Executive Vice President and Chief Operating Officer. Having previously served as Senior Vice President and Managing Director of the Willis Group's Environmental Practice in North America, Mr. Rodrigues brings over 25 years of expertise in insurance and risk management regarding environmental, health, safety, and toxic tort issues. Prior to Willis, Mr. Rodrigues served as Partner in Arthur Andersen's US-based Environmental, Health, and Safety- liability-focused practice.
Also from Willis, Michael Roche joins Green Reach Consulting as Senior Vice President and Managing Director. An attorney by trade, Mr. Roche is a toxic tort, products liability and regulatory compliance specialist. Prior to joining Green Reach, he practiced tort and insurance coverage law at Burns & Levinson and Donovan Hatem in Boston.
With an M.D. degree from the University of Illinois College of Medicine, a M.P.H. degree from the Harvard University School of Public Health, and medical residencies in Occupational Medicine and Medical Toxicology and in Internal Medicine, Dr. Bruce Gillis brings over 30 years of medical expertise as founder and CEO of The Cytokine Institute.
The Cytokine Institute provides a variety of consulting services in the area of litigation support, risk management, human resources, medical toxicology and healthcare. The organization developed DNA-based technologies, which provide vital information that is germane to Material Safety Data Sheets, the recently enacted REACH protocol and numerous other international, and United States rules and regulations concerning potentially harmful substances.
|SOURCE The Cytokine Institute|
Copyright©2007 PR Newswire.
All rights reserved